Enhanced external counter pulsation (EECP) for restless legs syndrome (RLS): Preliminary negative results in a parallel double-blind study

2006 ◽  
Vol 7 (4) ◽  
pp. 390-391 ◽  
Author(s):  
Sri-Sujanthy Rajaram ◽  
Peter Rudzinskiy ◽  
Arthur S. Walters
Keyword(s):  
Restless Legs Syndrome ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Restless Legs ◽  
Negative Results

Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study

2015 ◽  
Vol 16 (1) ◽  
pp. 181-185 ◽  
Author(s):  
Jingyu Zhang ◽  
Bin Liu ◽  
Yonghui Zheng ◽  
Tingting Chu ◽  
Zichao Yang
Keyword(s):  
Restless Legs Syndrome ◽  
Blind Study ◽  
Double Blind Study ◽  
Chinese People ◽  
Double Blind ◽  
Restless Legs

scholarly journals Treatment of the restless legs syndrome with carbamazepine: a double blind study.

BMJ ◽  
1984 ◽  
Vol 288 (6415) ◽  
pp. 444-446 ◽  
Author(s):  
W Telstad ◽  
O Sorensen ◽  
S Larsen ◽  
P E Lillevold ◽  
P Stensrud ◽  
...  
Keyword(s):  
Restless Legs Syndrome ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Restless Legs

Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study)

2007 ◽  
Vol 22 (2) ◽  
pp. 213-219 ◽  
Author(s):  
Wolfgang H. Oertel ◽  
Karin Stiasny-Kolster ◽  
Bettina Bergtholdt ◽  
Yngve Hallström ◽  
Jaan Albo ◽  
...  
Keyword(s):  
Restless Legs Syndrome ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Restless Legs

Prevention of Rheumatic Fever

1973 ◽  
Vol 12 (8) ◽  
pp. 501-503 ◽  
Author(s):  
Ham Jackson
Keyword(s):  
Side Effects ◽  
Antibiotic Therapy ◽  
Rheumatic Fever ◽  
Streptococcal Pharyngitis ◽  
Blind Study ◽  
Effective Drug ◽  
Double Blind Study ◽  
Double Blind ◽  
Negative Results ◽  
Group A

Poststreptococcal sequelae can be markedly reduced by antibiotic therapy which eradicates the organism from the pharynx. In a double blind study, the effectiveness of clindamycin palmitate liquid was compared with that of ampicillin for eradicating group A beta hemolytic streptococci from patients with pharyngitis. Cultures four days posttherapy were negative in 95 (93.2%) of 102 clindamycin treated patients and in 92 (87.6%) of 105 in the ampicillin group. Seventy-six clindamycin treated and 79 ampicillin treated patients had 28-day cultures with negative results in 69 (90.8%) and 67 (84.8%), respectively. Possible side effects were both mild and infrequent, 3.8 per cent from ampicillin and 2.6 per cent from clindamycin. It was concluded that clindamycin palmitate is palatable, relatively free of side effects and is an effective drug for treatment of streptococcal pharyngitis. No poststreptococcal sequelae occurred.

Sign in / Sign up

Export Citation Format

Share Document